Bringing you live news and features since 2006 

Direxion launches the Direxion mRNA ETF

Direxion has launched the Direxion mRNA ETF designed to offer investors exposure to messenger RNA technology, the cutting-edge research area that served as the basis for most COVID-19 vaccines. The Direxion mRNA ETF (MSGR) tracks the BITA Messenger RNA Technology Index.


The BITA Messenger RNA Technology Index is the world’s first pure-play mRNA technology focused index, the firm writes. The index tracks the performance of a selection of companies that have pure thematic exposure to the development and commercialisation of mRNA technology-based applications such as vaccines, therapeutics and development of medicines.

While the technology has come to the spotlight recently given the success of mRNA vaccines in preventing COVID-19 infections, the potential of this technology goes far beyond, the firm says. Riding current mRNA successes, numerous mRNA startups, spread mainly across the US and Europe, have secured approximately USD4.6 billion in investment flows.

David Mazza, Managing Director, Head of Product at Direxion says: “MSGR captures companies specifically involved with mRNA technologies that are believed to be at the forefront of fighting the battle against COVID, while also highlighting mRNA’s application to other viruses and diseases, including HIV and Lyme disease.”

M&A activity within the sector is booming as the technology is drawing attention from large corporations looking to revamp their R&D and medicine development platforms. An example of this is the USD3.2 billion acquisition of Translate Bio by Sanofi in September this year, the firm writes.

Victor Gomez, CEO at BITA, says: “From vaccines to cancer treatment, the mRNA technology will have a far-reaching impact in healthcare over the next years, given its potential to transform how medicines are discovered, developed, and manufactured. We are very happy and proud to be supporting Direxion in the launch of this highly innovative pure-play thematic ETF, which leverages BITA’s deep thematic expertise”. 

Latest News

Cerulli Associates, writing in the latest issue of The Cerulli Edge, analyses mutual fund and ETF flows as of December..
BUX, described by the firm as one of Europe’s fastest growing neobrokers, with more than one million users in Europe,..
SIX Swiss Exchange reports that the number of ETFs listed on SIX Swiss Exchange increased by 25 in the fourth..
Ossiam has announced the launch of a new ETF, the Ossiam Shiller Barclays CAPE Global Sector Value, listed on five..

Related Articles

We are very pleased to open the voting for service providers (selected by nominations) and ETP issuers, selected by our data partners, Trackinsight, for the European ETF Express Awards, in...
Osprey Funds’ founder and CEO, Greg King, has written an open letter to Barry Silbert, majority owner of Digital Currency Group which owns Grayscale, suggesting that he uses his powers...
Comparing multifactor ETFs to the popular Marvel Avengers series may seem a bit of a stretch but recent analysis from Morningstar suggests the investment strategies have more in common with...
Canadian asset manager Mackenzie Investments, with CAD186.6 billion under management, has published its annual Mackenzie Investments Year-End ETF Report. ...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by